Target Price | $175.39 |
Price | $134.43 |
Potential | 30.47% |
Number of Estimates | 54 |
54 Analysts have issued a price target NVIDIA 2026 . The average NVIDIA target price is $175.39. This is 30.47% higher than the current stock price. The highest price target is $220.00 63.65% , the lowest is $135.00 0.42% . | |
A rating was issued by 68 analysts: 62 Analysts recommend NVIDIA to buy, 6 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the NVIDIA stock has an average upside potential 2026 of 30.47% . Most analysts recommend the NVIDIA stock at Purchase. |
57 Analysts have issued a sales forecast NVIDIA 2025 . The average NVIDIA sales estimate is $129b . This is 14.24% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $133b 17.71% , the lowest is $124b 9.17% .
This results in the following potential growth metrics:
2024 | $60.9b | 125.85% |
---|---|---|
2025 | $129b | 112.40% |
2026 | $199b | 53.54% |
2027 | $240b | 20.69% |
2028 | $277b | 15.65% |
2029 | $264b | 4.84% |
20 Analysts have issued an NVIDIA EBITDA forecast 2025. The average NVIDIA EBITDA estimate is $85.2b . This is 17.13% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $90.6b 24.61% , the lowest is $78.8b 8.32% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $34.5b | 384.20% |
---|---|---|
2025 | $85.2b | 147.12% |
2026 | $130b | 52.53% |
2027 | $161b | 23.71% |
2028 | $177b | 10.05% |
2024 | 56.60% | 114.39% |
---|---|---|
2025 | 65.85% | 16.35% |
2026 | 65.41% | 0.67% |
2027 | 67.05% | 2.51% |
2028 | 63.81% | 4.83% |
31 NVIDIA Analysts have issued a net profit forecast 2025. The average NVIDIA net profit estimate is $69.9b . This is 12.24% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $72.5b 16.54% , the lowest is $67.4b 8.27% .
This results in the following potential growth metrics and future Net Margins:
2024 | $29.2b | 600.00% |
---|---|---|
2025 | $69.9b | 139.57% |
2026 | $105b | 49.77% |
2027 | $132b | 25.81% |
2028 | $157b | 19.33% |
2024 | 47.87% | 209.93% |
---|---|---|
2025 | 54.00% | 12.80% |
2026 | 52.67% | 2.46% |
2027 | 54.90% | 4.23% |
2028 | 56.65% | 3.19% |
31 Analysts have issued a NVIDIA forecast for earnings per share. The average NVIDIA <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $2.85 . This is 12.20% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $2.96 16.54% , the lowest is $2.75 8.27% .
This results in the following potential growth metrics and future valuations:
2024 | $1.19 | 600.00% |
---|---|---|
2025 | $2.85 | 139.50% |
2026 | $4.27 | 49.82% |
2027 | $5.37 | 25.76% |
2028 | $6.41 | 19.37% |
Current | 52.95 | 12.97% |
---|---|---|
2025 | 47.15 | 10.95% |
2026 | 31.48 | 33.23% |
2027 | 25.03 | 20.49% |
2028 | 20.97 | 16.22% |
Based on analysts' sales estimates for 2025, the NVIDIA stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 25.22 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 25.44 .
This results in the following potential growth metrics and future valuations:
Current | 28.82 | 1.03% |
---|---|---|
2025 | 25.22 | 12.48% |
2026 | 16.43 | 34.87% |
2027 | 13.61 | 17.14% |
2028 | 11.77 | 13.53% |
2029 | 12.37 | 5.08% |
Current | 29.07 | 1.03% |
---|---|---|
2025 | 25.44 | 12.46% |
2026 | 16.57 | 34.87% |
2027 | 13.73 | 17.14% |
2028 | 11.87 | 13.53% |
2029 | 12.48 | 5.08% |
Analyst | Rating | Action | Date |
---|---|---|---|
Tigress Financial | Buy ➜ Strong Buy | Upgrade | Jan 28 2025 |
Morgan Stanley | Overweight ➜ Overweight | Unchanged | Jan 28 2025 |
Cantor Fitzgerald | Overweight ➜ Overweight | Unchanged | Jan 27 2025 |
Barclays | Overweight ➜ Overweight | Unchanged | Jan 17 2025 |
HSBC | Buy ➜ Buy | Unchanged | Jan 13 2025 |
Rosenblatt | Buy ➜ Buy | Unchanged | Jan 08 2025 |
Benchmark | Buy ➜ Buy | Unchanged | Jan 07 2025 |
Analyst Rating | Date |
---|---|
Upgrade
Tigress Financial: Buy ➜ Strong Buy
|
Jan 28 2025 |
Unchanged
Morgan Stanley: Overweight ➜ Overweight
|
Jan 28 2025 |
Unchanged
Cantor Fitzgerald: Overweight ➜ Overweight
|
Jan 27 2025 |
Unchanged
Barclays: Overweight ➜ Overweight
|
Jan 17 2025 |
Unchanged
HSBC: Buy ➜ Buy
|
Jan 13 2025 |
Unchanged
Rosenblatt: Buy ➜ Buy
|
Jan 08 2025 |
Unchanged
Benchmark: Buy ➜ Buy
|
Jan 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.